EXELIXIS contributes to new research on governing AI in cancer care
Our CEO, Dr Kalliopi Thanopoulou, is a co-author of a new MULTIR consortium paper translating patient perspectives into practical recommendations for trustworthy AI in oncology.

Original updates and practical perspectives prepared for the European research and innovation community.
Our CEO, Dr Kalliopi Thanopoulou, is a co-author of a new MULTIR consortium paper translating patient perspectives into practical recommendations for trustworthy AI in oncology.
The consultation seeks evidence on how the portfolio, design, governance and implementation of European Partnerships should evolve under the next programme.
Revised guidance covers the EIC Fund’s investment approach, safeguards, TRLs, follow-on investments, intellectual property and the larger STEP Scaleup investment amounts.
The European Commission has completed the legal establishment of a new fund targeting €5 billion to help Europe’s most promising deep-tech companies scale globally.
Japanese organisations can now participate in Horizon Europe Pillar II on terms equivalent to entities from EU Member States.
The Council’s partial negotiating position sets priorities for governance, simplification, partnerships, research security and the programme’s link with European competitiveness.
Australian organisations are expected to gain direct access to Horizon Europe Pillar II funding from January 2027 under a transitional arrangement.